322 related articles for article (PubMed ID: 25239471)
1. Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes.
Blattler A; Yao L; Witt H; Guo Y; Nicolet CM; Berman BP; Farnham PJ
Genome Biol; 2014 Sep; 15(9):469. PubMed ID: 25239471
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
[TBL] [Abstract][Full Text] [Related]
3. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
Jacinto FV; Ballestar E; Esteller M
Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
5. Reversible Regulation of Promoter and Enhancer Histone Landscape by DNA Methylation in Mouse Embryonic Stem Cells.
King AD; Huang K; Rubbi L; Liu S; Wang CY; Wang Y; Pellegrini M; Fan G
Cell Rep; 2016 Sep; 17(1):289-302. PubMed ID: 27681438
[TBL] [Abstract][Full Text] [Related]
6. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
Weber M; Hellmann I; Stadler MB; Ramos L; Pääbo S; Rebhan M; Schübeler D
Nat Genet; 2007 Apr; 39(4):457-66. PubMed ID: 17334365
[TBL] [Abstract][Full Text] [Related]
7. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
8. Conserved role of intragenic DNA methylation in regulating alternative promoters.
Maunakea AK; Nagarajan RP; Bilenky M; Ballinger TJ; D'Souza C; Fouse SD; Johnson BE; Hong C; Nielsen C; Zhao Y; Turecki G; Delaney A; Varhol R; Thiessen N; Shchors K; Heine VM; Rowitch DH; Xing X; Fiore C; Schillebeeckx M; Jones SJ; Haussler D; Marra MA; Hirst M; Wang T; Costello JF
Nature; 2010 Jul; 466(7303):253-7. PubMed ID: 20613842
[TBL] [Abstract][Full Text] [Related]
9. Pax6 associates with H3K4-specific histone methyltransferases Mll1, Mll2, and Set1a and regulates H3K4 methylation at promoters and enhancers.
Sun J; Zhao Y; McGreal R; Cohen-Tayar Y; Rockowitz S; Wilczek C; Ashery-Padan R; Shechter D; Zheng D; Cvekl A
Epigenetics Chromatin; 2016; 9(1):37. PubMed ID: 27617035
[TBL] [Abstract][Full Text] [Related]
10. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of intronic enhancers directs tissue-specific expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP).
Hoivik EA; Bjanesoy TE; Mai O; Okamoto S; Minokoshi Y; Shima Y; Morohashi K; Boehm U; Bakke M
Endocrinology; 2011 May; 152(5):2100-12. PubMed ID: 21343250
[TBL] [Abstract][Full Text] [Related]
12. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
13. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
14. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
Müller I; Wischnewski F; Pantel K; Schwarzenbach H
BMC Cancer; 2010 Jun; 10():297. PubMed ID: 20565761
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes.
Aran D; Sabato S; Hellman A
Genome Biol; 2013 Mar; 14(3):R21. PubMed ID: 23497655
[TBL] [Abstract][Full Text] [Related]
16. Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer.
Bae MG; Kim JY; Choi JK
BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):38. PubMed ID: 27534853
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.
Han H; Cortez CC; Yang X; Nichols PW; Jones PA; Liang G
Hum Mol Genet; 2011 Nov; 20(22):4299-310. PubMed ID: 21835883
[TBL] [Abstract][Full Text] [Related]
18. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
19. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity.
Schmidl C; Klug M; Boeld TJ; Andreesen R; Hoffmann P; Edinger M; Rehli M
Genome Res; 2009 Jul; 19(7):1165-74. PubMed ID: 19494038
[TBL] [Abstract][Full Text] [Related]
20. STAT5 Regulation of Sex-Dependent Hepatic CpG Methylation at Distal Regulatory Elements Mapping to Sex-Biased Genes.
Hao P; Waxman DJ
Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33199496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
